These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

842 related items for PubMed ID: 11390699

  • 1. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S, Little S, Friedlander A, Fritz D, Fellows P.
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [Abstract] [Full Text] [Related]

  • 2. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK, Rossi CA, Kang AS, Morrow PR, Lee JS, Welkos SL.
    Microb Pathog; 2005 Jun; 38(5-6):209-25. PubMed ID: 15925272
    [Abstract] [Full Text] [Related]

  • 3. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T, Israeli M, Rotem S, Elia U, Bar-Haim E, Ehrlich S, Cohen O, Shafferman A.
    Vaccine; 2017 Oct 20; 35(44):6030-6040. PubMed ID: 28342664
    [Abstract] [Full Text] [Related]

  • 4. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against B. anthracis Spores and Toxin.
    Majumder S, Das S, Somani VK, Makam SS, Kingston JJ, Bhatnagar R.
    Front Immunol; 2019 Oct 20; 10():498. PubMed ID: 30941133
    [Abstract] [Full Text] [Related]

  • 5. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
    Cybulski RJ, Sanz P, McDaniel D, Darnell S, Bull RL, O'Brien AD.
    Vaccine; 2008 Sep 08; 26(38):4927-39. PubMed ID: 18657585
    [Abstract] [Full Text] [Related]

  • 6. In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.
    Welkos S, Friedlander A, Weeks S, Little S, Mendelson I.
    J Med Microbiol; 2002 Oct 08; 51(10):821-831. PubMed ID: 12435060
    [Abstract] [Full Text] [Related]

  • 7. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I, Gat O, Aloni-Grinstein R, Altboum Z, Inbar I, Kronman C, Bar-Haim E, Cohen S, Velan B, Shafferman A.
    Vaccine; 2005 Dec 01; 23(48-49):5688-97. PubMed ID: 16039760
    [Abstract] [Full Text] [Related]

  • 8. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
    Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW.
    Infect Immun; 2009 Apr 01; 77(4):1649-63. PubMed ID: 19168734
    [Abstract] [Full Text] [Related]

  • 9. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W.
    Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738
    [Abstract] [Full Text] [Related]

  • 10. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino SI.
    Microbiology (Reading); 2006 Oct 01; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
    Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.
    Infect Immun; 2009 Mar 01; 77(3):1197-207. PubMed ID: 19114543
    [Abstract] [Full Text] [Related]

  • 12. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY, Chun JH, Ha HJ, Park J, Kim BS, Oh HB, Rhie GE.
    FEMS Immunol Med Microbiol; 2009 Nov 01; 57(2):165-72. PubMed ID: 19732139
    [Abstract] [Full Text] [Related]

  • 13. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I, Bar-David E, Sittner A, Weiss S, Schlomovitz J, Ben-Shmuel A, Mechaly A, Altboum Z, Kobiler D, Levy H.
    Antimicrob Agents Chemother; 2016 Aug 01; 60(8):4878-85. PubMed ID: 27270276
    [Abstract] [Full Text] [Related]

  • 14. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
    Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.
    Proc Natl Acad Sci U S A; 2004 Sep 14; 101(37):13601-6. PubMed ID: 15342913
    [Abstract] [Full Text] [Related]

  • 15. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR.
    Infect Immun; 2007 Aug 14; 75(8):4020-9. PubMed ID: 17502384
    [Abstract] [Full Text] [Related]

  • 16. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 17. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK, Gross T, Larabee J, Pate L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Collins LC, Spooner CE, Chen H, Ballard J, James JA, Farris AD.
    Clin Vaccine Immunol; 2017 Nov 01; 24(11):. PubMed ID: 28877928
    [Abstract] [Full Text] [Related]

  • 18. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM, Buyuk F, Celebi O, Demiraslan H, Doganay M, Sahin M, Moehring J, Ndumnego OC, Otlu S, van Heerden H, Beyer W.
    BMC Vet Res; 2017 Jul 12; 13(1):220. PubMed ID: 28701192
    [Abstract] [Full Text] [Related]

  • 19. Anthrax spores make an essential contribution to vaccine efficacy.
    Brossier F, Levy M, Mock M.
    Infect Immun; 2002 Feb 12; 70(2):661-4. PubMed ID: 11796596
    [Abstract] [Full Text] [Related]

  • 20. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD, Wilder JA, Mega WM, Hutt JA, Kuehl PJ, Valderas MW, Chew LL, Liang BC, Squires CH.
    PLoS One; 2015 Feb 12; 10(7):e0130952. PubMed ID: 26207820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.